New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis

Brain

Volumn 138, Issue 4, 2015, Pages 902-917

  Hoppmann, Nicola ^a   Graetz, Christiane ^a   Paterka, Magdalena ^a   Poisa Beiro, Laura ^a   Larochelle, Catherine ^a   Hasan, Maruf ^a   Lill, Christina M ^a,b,c   Zipp, Frauke ^a   Siffrin, Volker ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

experimental autoimmune encephalomyelitis; GWAS; multiple sclerosis; plasticity; transcriptome analysis

Indexed keywords

LIVER X RECEPTOR; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CHOLESTEROL SYNTHESIS; EFFECTOR CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENE EXPRESSION; GENETIC RISK; GENETIC SUSCEPTIBILITY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; ANIMAL; C57BL MOUSE; GENE REGULATORY NETWORK; GENETICS; HUMAN; KNOCKOUT MOUSE; PATHOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE REGULATORY NETWORKS; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPLE SCLEROSIS;

EID: 84929093567     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu408     Document Type: Article

References (82)

1. Agenès F, Bosco N, Mascarell L, Fritah S, Ceredig R. Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naïve and regulatory T cells. Immunology 2005; 115: 179-88.
2. An J, Golech S, Klaewsongkram J, Zhang Y, Subedi K, Huston GE, et al. Krüppel-like factor 4 (KLF4) directly regulates proliferation in thymocyte development and IL-17 expression during Th17 differentiation. FASEB J 2011; 25: 3634-45.
3. Batoulis H, Recks MS, Addicks K, Kuerten S. Experimental autoimmune encephalomyelitis-achievements and prospective advances. APMIS 2011; 119: 819-30.
4. Bending D, La Peña HD, Veldhoen M, Phillips JM, Uyttenhove C, Stockinger B, et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 2009; 119: 565-72.
5. Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, Hausner MA, et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 2008; 134: 97-111.
6. Bertrams J, Kuwert E. HL-A antigen frequencies in multiple sclerosis. Eur Neurol 1972; 7: 74-8.
7. Bielekova B. Daclizumab therapy for multiple sclerosis. Neurotherapeutics 2013; 10: 55-67.
8. Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD, Todd JA, et al. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf) 2007; 66: 508-12.
9. Brucklacher-Waldert V, Stuerner K, Kolster M, Wolthausen J, Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009; 132: 3329-41.
10. Carotta S, Wu L, Nutt SL. Surprising new roles for PU.1 in the adaptive immune response. Immunol Rev 2010; 238: 63-75.
11. Castrillo A, Joseph SB, Vaidya SA, Haberland M, Fogelman AM, Cheng G, et al. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 2003; 12: 805-16.
12. Chang H-C, Zhang S, Thieu VT, Slee RB, Bruns HA, Laribee RN, et al. PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity 2005; 22: 693-703.
13. Codarri L, Gyü lvészi G, Tosevski V, Hesske L, Fontana A, Magnenat L, et al. RORgt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 2011; 12: 560-7.
14. Crellin NK, Garcia RV, Hadisfar O, Allan SE, Steiner TS, Levings MK. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol 2005; 175: 8051-9.
15. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744-8.
16. Cui G, Qin X, Wu L, Zhang Y, Sheng X, Yu Q, et al. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J Clin Invest 2011; 121: 658-70.
17. Ding Y, Kantarci A, Badwey JA, Hasturk H, Malabanan A, Van Dyke TE. Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus. J Immunol 2007; 179: 647-54.
18. Drieschner N, Kerschling S, Soller JT, Rippe V, Belge G, Bullerdiek J, et al. A domain of the thyroid adenoma associated gene (THADA) conserved in vertebrates becomes destroyed by chromosomal rearrangements observed in thyroid adenomas. Gene 2007; 403: 110-7.
19. Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207-10.
20. Ehrchen JM, Sunderkö tter C, Foell D, Vogl T, Roth J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 2009; 86: 557-66.
21. El-Behi M, Ciric B, Dai H, Yan Y, Cullimore M, Safavi F, et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 2011; 12: 568-75.
22. Gelman AE, Zhang J, Choi Y, Turka LA. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol 2004; 172: 6065-73.
23. Gibbons DL, Abeler-Dörner L, Raine T, Hwang I-Y, Jandke A, Wencker M, et al. Cutting edge: regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential. J Immunol 2011; 187: 2067-71.
24. Giorelli M, Livrea P, Minervini MG, Trojano M. Immunomodulatory properties of increased levels of liver X receptor beta in peripheral blood mononuclear cells from multiple sclerosis patients. Exp Neurol 2007; 204: 759-66.
25. Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006; 129: 1953-71.
26. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier M-C. Vitamin D and inflammation. Joint Bone Spine 2010; 77: 552-7.
27. Hartmann FJ, Khademi M, Aram J, Ammann S, Kockum I, Constantinescu C, et al. Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells. Nat Commun 2014; 5: 5056.
28. Hegazy AN, Peine M, Helmstetter C, Panse I, Fröhlich A, Bergthaler A, et al. Interferons direct Th2 cell reprogramming to generate a stable GATA-3( + )T-bet( + ) cell subset with combined Th2 and Th1 cell functions. Immunity 2010; 32: 116-28.
29. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, Cua DJ, et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 2011; 12: 255-63.
30. IMSGC, WTCCC2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-9.
31. IMSGC. Network-based multiple sclerosis pathway analysis with GWAS data from 15, 000 cases and 30, 000 controls. Am J Hum Genet 2013a; 92: 854-65.
32. IMSGC. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013b; 45: 1353-60.
33. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell 2006; 126: 1121-33.
34. Izsepi E, Himer L, Szilagyi O, Hajdu P, Panyi G, Laszlo G, et al. Membrane microdomain organization, calcium signal, and NFAT activation as an important axis in polarized Th cell function. Cytometry A 2013; 83: 185-96.
35. Johnson NL, Kemp AW, Kotz S. Univariate discrete distributions. 3rd edn. Hoboken (NJ): Wiley; 2005.
36. Kambe T. An overview of a wide range of functions of ZnT and Zip Zinc transporters in the secretory pathway. Biosci Biotechnol Biochem 2011; 75: 1036-43.
37. Kanno Y, Vahedi G, Hirahara K, Singleton K, O'Shea JJ. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu Rev Immunol 2012; 30: 707-31.
38. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res 2002; 12: 996-1006.
39. Kirschke CP, Huang L. ZnT7, a novel mammalian zinc transporter, accumulates zinc in the Golgi apparatus. J Biol Chem 2003; 278: 4096-102.
40. Komai-Koma M, Jones L, Ogg GS, Xu D, Liew FY. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci USA 2004; 101: 3029-34.
41. Kurschus FC, Croxford AL, Heinen AP, Wö rtge S, Ielo D, Waisman A. Genetic proof for the transient nature of the Th17 phenotype. Eur J Immunol 2010; 40: 3336-46.
42. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233-40.
43. Lee YK, Turner H, Maynard CL, Oliver JR, Elson CO, Weaver CT. Late developmental plasticity in the T helper 17 lineage. Immunity 2009; 30: 92-107.
44. Lexberg MH, Taubner A, Albrecht I, Lepenies I, Richter A, Kamradt T, et al. IFN-g and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells. Eur J Immunol 2010; 40: 3017-27.
45. Li Q, Lu Q, Lu H, Tian S, Lu Q. Systemic autoimmunity in TAM triple knockout mice causes inflammatory brain damage and cell death. PLoS One 2013; 8: e64812.
46. Lian L, Wang Y, Flick M, Choi J, Scott EW, Degen J, et al. Loss of pleckstrin defines a novel pathway for PKC-mediated exocytosis. Blood 2009; 113: 3577-84.
47. Livac K, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C)T method. Methods 2001; 25: 402-408.
48. Lowe CE, Cooper JD, Brusko T, Walker NM, Smyth DJ, Bailey R, et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet 2007; 39: 1074-82.
49. Maier LM, Anderson DE, Severson CA, Baecher-Allan C, Healy B, Liu D V, et al. Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses. J Immunol 2009; 182: 1541-7.
50. Mansson A, Adner M, Cardell LO. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir Res 2006; 7: 36.
51. Montes M, Zhang X, Berthelot L, Laplaud D-A, Brouard S, Jin J, et al. Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clin Immunol 2009; 130: 133-44.
52. Naito S, Namerow N, Mickey M, Terasaki P. Multiple sclerosis: association with HL-A3. Tissue Antigens 1972; 2: 1-4.
53. Noster R, Riedel R, Mashreghi M-F, Radbruch H, Harms L, Haftmann C, et al. IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells. Sci Transl Med 2014; 6: 241ra80.
54. Nunomura S, Sato T, Habu S. Molecular basis for functional maturation of thymocytes: increase in c-fos translation with positive selection. J Immunol 2000; 164: 5590-5.
55. Ouyang X, Zhang R, Yang J, Li Q, Qin L, Zhu C, et al. Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat Commun 2011; 2: 314.
56. Patra AK, Avots A, Zahedi RP, Schü ler T, Sickmann A, Bommhardt U, et al. An alternative NFAT-activation pathway mediated by IL-7 is critical for early thymocyte development. Nat Immunol 2013; 14: 127-35.
57. Patsopoulos NA, Esposito F, Reischl J, Lehr S, Bauer D, Heubach J, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011; 70: 897-912.
58. Peck A, Mellins ED. Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 2010; 129: 147-53.
59. Petersen C, Aumü ller G, Bahrami M, Hoyer-Fender S. Molecular cloning of Odf3 encoding a novel coiled-coil protein of sperm tail outer dense fibers. Mol Reprod Dev 2002; 61: 102-12.
60. Rothenberg EV, Dionne CJ. Lineage plasticity and commitment in T-cell development. Immunol Rev 2002; 187: 96-115.
61. Schweingruber N, Reichardt SD, Lü hder F, Reichardt HM. Mechanisms of glucocorticoids in the control of neuroinflammation. J Neuroendocrinol 2012; 24: 174-82.
62. Siffrin V, Brandt AU, Herz J, Zipp F. New insights into adaptive immunity in chronic neuroinflammation. Adv Immunol 2007; 96: 1-40.
63. Siffrin V, Radbruch H, Glumm R, Niesner R, Paterka M, Herz J, et al. In vivo imaging of partially reversible th17 cell-induced neuronal dys-functioninthe courseofencephalomyelitis. Immunity 2010; 33: 424-36.
64. Simmons SB, Pierson ER, Lee SY, Goverman JM. Modeling the heterogeneity of multiple sclerosis in animals. Trends Immunol 2013; 34: 410-22.
65. Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 2008; 194: 7-17.
66. Soroosh P, Doherty TA. Th9 and allergic disease. Immunology 2009; 127: 450-8.
67. Tait AS, Butts CL, Sternberg EM. The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease. J Leukoc Biol 2008; 84: 924-31.
68. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
69. Tontonoz P, Mangelsdorf DJ. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 2003; 17: 985-93.
70. Tsukumo S, Unno M, Muto A, Takeuchi A, Kometani K, Kurosaki T, etal. Bach2 maintains T cells in a naive state by suppressing effector memory-related genes. Proc Natl Acad Sci USA 2013; 110: 10735-40.
71. Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 2008; 172: 146-55.
72. Weinger JG, Omari KM, Marsden K, Raine CS, Shafit-Zagardo B. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions. Am J Pathol 2009; 175: 283-93.
73. Weinstock-Guttman B, Zivadinov R, Mahfooz N, Carl E, Drake A, Schneider J, et al. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation 2011; 8: 127.
74. Wen X, Liu H, Xiao G, Liu X. Downregulation of the transcription factor KLF4 is required for the lineage commitment of T cells. Cell Res 2011; 21: 1701-10.
75. Weng L, Dai H, Zhan Y, He Y, Stepaniants SB, Bassett DE. Rosetta error model for gene expression analysis. Bioinformatics 2006; 22: 1111-21.
76. Yang D, Thangaraju M, Browning DD, Dong Z, Korchin B, Lev DC, etal. IFN regulatory factor 8 mediates apoptosis in nonhemopoietic tumor cells via regulation of fas expression. J Immunol 2007; 179: 4775-82.
77. Yang K, Chi H. Metabolic control of Th17 cell generation and CNS inflammation. J Neurol Neurophysiol 2014, S12.
78. Yeh W-I, McWilliams IL, Harrington LE. Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitis. J Immunol 2011a; 187: 4998-5006.
79. Yeh W-I, McWilliams IL, Harrington LE. Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitis. J Immunol 2011b; 187: 4998-5006.
80. Zastepa E, Fitz-Gerald L, Hallett M, Antel J, Bar-Or A, Baranzini S, et al. Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MS. Neurology 2014; 82: 681-90.
81. Zhang R, Chen K, Peng L, Xiong H. Regulation of T helper cell differentiation by interferon regulatory factor family members. Immunol Res 2012; 54: 169-76.
82. Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res 2010; 20: 4-12.